Skip Navigation
Skip to contents

Headache and Pain Research : Headache and Pain Research

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Eiichiro Nagata 1 Article
Prevalence of Gastrointestinal Disorders in Patients with Migraine: An Insurance Claims Database Study in Japan
Eiichiro Nagata, Miki Hasebe, Daishi Yui, Alex Wang, Robert Urman, Katarzyna Jabłońska, Renata Majewska, Mamoru Shibata
Received August 21, 2026  Accepted October 13, 2026  Published online October 27, 2026  
DOI: https://doi.org/10.62087/hpr.2026.0038
  • 0 View
  • 0 Download
AbstractAbstract
Purpose: Migraine is often associated with gastrointestinal (GI) comorbidities. This study estimated the 1-year prevalence of five GI disorders in patients with and without migraine.
Methods
This cross-sectional study used data from a Japanese health insurance claims database for two periods: April 1, 2019–March 31, 2020, and April 1, 2020–March 31, 2021. Individuals with a migraine diagnosis or a triptan prescription constituted the migraine group, and those with at least two non-migraine claims constituted the non-migraine group. The 1-year prevalence was assessed for any constipation, refractory constipation, constipation-predominant irritable bowel syndrome (IBS-C), diarrhea, and diarrhea-predominant irritable bowel syndrome (IBS-D).
Results
The migraine and non-migraine groups included 75,720 and 993,198 patients, respectively, in Period 1 and 82,945 and 978,071 patients, respectively, in Period 2. The 1-year prevalence of any constipation in the migraine and non-migraine groups was 12.1% (95% confidence interval [CI]: 11.9%–12.4%) and 5.9% (95% CI: 5.9%–6.0%), respectively. The corresponding prevalence estimates were 2.0% (95% CI: 1.9%–2.1%) and 0.8% (95% CI: 0.8%–0.8%) for refractory constipation; 1.5% (95% CI: 1.4%–1.6%) and 0.5% (95% CI: 0.5%–0.5%) for IBS-C; 4.5% (95% CI: 4.3%–4.6%) and 2.1% (95% CI: 2.1%–2.2%) for diarrhea; and 2.1% (95% CI: 2.0%–2.2%) and 0.6% (95% CI: 0.6%–0.6%) for IBS-D. Among patients with migraine, any constipation was present in 21.4% (95% CI: 21.0%–21.8%) of those prescribed prophylactic medication and 3.2% (95% CI: 3.0%–3.3%) of those not prescribed such medication.
Conclusion
Physicians should recognize how frequently GI disorders occur in patients with migraine, discuss these conditions with patients, and advise them on appropriate management.

Headache and Pain Research : Headache and Pain Research
TOP